Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
pulmonary fibrosis/hypoxia
Länken sparas på Urklipp
Sida 1 från 19 resultat
Post Covid-19 Cardiopulmonary and Immunological Changes
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
• Background and significance:
COVID-19 (Coronavirus Disease-2019) is a public health emergency of international concern. Radiological, lung function changes were reported in different studies of pulmonary viral infection.
After a patient has recovered from severe acute respiratory syndrome (SARS),
Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic. The outbreak started in Wuhan, Hubei province, China, in December 2019 and the World Health Organization (WHO) recognized it as a pandemic on 11 March 2020. Up to Apr 9. 2020 there are more than 2 million confirmed cases,
Assessment of Continuous Positive Airway Pressure Therapy in IPF
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic disease of the peripheral lung parenchyma that affects 0.5% of older adults in the U.S. and confers a very poor median survival. Repetitive injury to the lung with abnormal healing likely results in fibrosis as treatment of those risk
The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Idiopathic pulmonary fibrosis (IPF) is a progressive form of lung scarring for which there is no proven treatment. Steroids and other potentially toxic drugs are often used but their efficacy is uncertain. The management of patients with IPF is particularly complex because firstly there
Acute Effects of Oxygen Supplementation Among IPF Patients
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Feasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Background:
Idiopathic Pulmonary Fibrosis (IPF) is a progressive fibrotic lung disease of unknown cause with a median survival of 3-5 years (Raghu et al. 2011). As the disease progresses, worsening of lung function and gas exchange impairment cause hypoxemia during physical activity leading to a
Lung Ultrasound Guided Protocol for Fluid Management for the Critically Ill Patient: a Randomized Study
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Inclusion criteria
- Age 18 or older admitted to the Intensive Care Unit
Exclusion criteria
- Due to LUS measurement limitation: patients with known persistent pleurisy, pulmonary fibrosis or pneumectomy;
- Unwillingness to participate in the study.
Active arm diuretic administration algorithm
-
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The investigators hypothesize that PR service with supplemented oxygen supply regardless of hypoxemia may have significantly better short-term effects in patients with IPF. The study will take place in Corfu General Hospital, by the Departments of Pulmonary Medicine and Physiotherapy and
Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFPEF Patients Treated With Allogeneic CDCs
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Heart failure with Preserved Ejection Fraction (HFPEF) is a distinct clinical heart failure syndrome and represents a critical unmet need in cardiovascular medicine. HFPEF patients have a marked increase in morbidity and mortality and a profound clinical disability. However, to date, no management
Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Langerhans cells are antigen-presenting cells of monocyte-macrophage lineage present in various epithelium like airways. Langerhans cell histiocytosis (LCH), also called histiocytosis X or pulmonary eosinophilic granulomatosis, are characterized by proliferation and infiltration of Langerhans cells
Predictors of Mortality in Patients With Advanced Lung Disease in Home Oxygen Therapy
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The advanced chronic lung disease (PAD) is characterized by the development of several structural abnormalities, and pulmonary and systemic functional with low potential for reversibility, in spite of the treatment. It is defined DPA whole lung non-neoplastic chronic in its final phase. Most people
Auto-titrating Oxygen in Chronic Respiratory Failure
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
For patients with chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), disease progression leads to hypoxic respiratory failure necessitating the use of long-term oxygen therapy (LTOT). However a number of studies have shown that despite being on LTOT at home many
Extravascular Lung Water and Pulmonary Vascular Permeability After Minimally Invasive Cardiac Surgery
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Acute respiratory distress syndrome (ARDS) occur with an incidence of 12% after cardiac surgery with the use of cardiopulmonary bypass (CBP). Using one-lung ventilation (OLV) in addition, as it is common practice in minimally invasive cardiac surgery (MICS), one can hypothesize that the risk for
Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Idiopathic Pulmonary Fibrosis (IPF) is a progressive and debilitating lung disease characterized by interstitial fibrosis with decreasing lung volumes and pulmonary insufficiency eventually resulting in death. Patients with Idiopathic Pulmonary Fibrosis (IPF) typically present with complaints of sub
Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Sildenafil is a cyclic GMP selective phosphodiesterase type 5 inhibitor approved for use by the FDA in patients with pulmonary arterial hypertension. There has been recent interest in the use of the drug in patients with diffuse parenchymal lung diseases. This is largely based on sildenafil's
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
